document type sequence filename description text html head title title head body bgcolor white style margin margin bottom font size font family time roman align right exhibit style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width style font family time roman font size valign style border solid padding left padding right style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center confidential material omitted filed separately with style margin margin bottom font size font family time roman align center security exchange commission double asterisk denote omission style font size margin margin bottom align left nbsp table style margin margin bottom font size font family time roman execution copy style margin margin bottom font size font family time roman align center small ermination small small small small ransition small small greement small style margin margin bottom text indent font size font family time roman small small small ermination small small small small ransition small small greement small transition agreement made february nbsp termination date between small ebiopharm small nbsp small nternational small swiss corporation having principal place business forum laquo egrave demain raquo chemin messidor lausanne switzerland debiopharm small uris small nbsp small small corporation established under state delaware having principal place business nbsp maguire road lexington united state america curis style margin margin bottom font size font family time roman align center small ecitals small style margin margin bottom text indent font size font family time roman small hereas small debiopharm curis party that certain license agreement effective august nbsp dated august nbsp amended october nbsp nbsp march nbsp february nbsp july nbsp nbsp march nbsp november nbsp collectively license agreement style margin margin bottom text indent font size font family time roman small hereas small debiopharm curis desire terminate license agreement provide orderly transition right responsibility obligation relating compound product from debiopharm curis manner that minimizes disruption product development term condition forth herein style margin margin bottom text indent font size font family time roman small small small herefore small consideration foregoing premise mutual covenant contained herein other good valuable consideration receipt sufficiency which hereby acknowledged debiopharm curis agree follows style margin margin bottom font size font family time roman small efined small small erms small capitalized term used otherwise defined herein shall have meaning provided license agreement addition following term shall have respective meaning provided below style margin margin bottom text indent font size font family time roman debio nbsp shall mean debiopharm clinical trial application ctas study concerning compound including ctas study including amendment thereto declaration trial each aforementioned study style margin margin bottom text indent font size font family time roman eudract shall mean european union drug regulating authority clinical trial which european database clinical trial investigational medicinal product style margin margin bottom text indent font size font family time roman halo trial shall mean that certain debiopharm sponsored clinical trial product described debiopharm protocol nbsp style margin margin bottom text indent font size font family time roman exclusive license shall have meaning provided paragraph nbsp this transition agreement style margin margin bottom text indent font size font family time roman termination date shall have meaning provided introductory paragraph this transition agreement style margin margin bottom text indent font size font family time roman transition period shall mean period beginning termination date expiring thereafter style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman small ermination small small small small icense small small greement small style margin margin bottom text indent font size font family time roman license agreement termination date license agreement hereby terminated effective termination date style margin margin bottom text indent font size font family time roman consequence termination license agreement shall deemed have been terminated pursuant section nbsp license agreement such termination shall subject provision section nbsp license agreement which section hereby incorporated reference this transition agreement except section nbsp license agreement which superseded term forth below this paragraph nbsp termination date style margin margin bottom text indent font size font family time roman curis will make each following time payment debiopharm style margin margin bottom text indent font size font family time roman seven hundred fifty thousand united state dollar within fifteen nbsp termination date which consideration debiopharm providing material defined paragraph this transition agreement curis described paragraph nbsp this transition agreement style margin margin bottom text indent font size font family time roman three million united state dollar within thirty nbsp after first dosing first patient first phase nbsp anywhere territory style margin margin bottom text indent font size font family time roman million united state dollar within thirty nbsp after receipt first marketing approval product united state america major european market whichever occurs first style margin margin bottom text indent font size font family time roman curis will debiopharm royalty rate three percent nbsp curis sale defined below product royalty curis sale will payable country country basis from first commercial sale product country territory ending upon later nbsp expiration last expire valid claim debiopharm patent which valid claim cover composition matter method manufacture product compound contained therein such country nbsp tenth nbsp anniversary first commercial sale product such country purpose this paragraph nbsp definition sale forth article license agreement shall apply mutatis mutandis define term curis sale style margin margin bottom text indent font size font family time roman curis shall debiopharm percent nbsp curis sublicensee royalty defined below purpose this paragraph nbsp curis sublicensee royalty shall mean royalty paid third party sublicensees curis affiliate with respect sale product such third party sublicensees their respective further sublicensees style margin margin bottom text indent font size font family time roman curis shall debiopharm nbsp fifteen percent nbsp curis sublicensee payment defined below attributable grant license sublicense develop commercialize product other than psoriasis product defined below provided that maximum aggregate amount payable curis debiopharm under this clause nbsp twenty million united state dollar nbsp fifteen percent nbsp curis sublicensee payment attributable grant license sublicense develop commercialize psoriasis product purpose this paragraph nbsp curis sublicensee payment shall mean amount paid third party sublicensees curis style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman affiliate connection with grant license sublicense with respect product except that curis sublicensee payment shall exclude nbsp curis sublicensee royalty nbsp amount paid curis third party sublicensees reimburse expense incurred curis support patent cost purchase curis equity provided that consideration received curis such equity exceed fair market value such equity psoriasis product shall mean product topical formulation local font style white space nowrap systemic font delivery treatment psoriasis style margin margin bottom text indent font size font family time roman avoidance doubt party acknowledge agree that nbsp license granted curis debiopharm under section nbsp license agreement terminated reverted curis termination date nbsp section nbsp license agreement terminated termination date shall further force effect nbsp license regarding development diagnostics product granted curis debiopharm under amendment dated nbsp terminated notwithstanding section nbsp this amendment dated nbsp shall deemed have been terminated accordance with section nbsp this amendment dated nbsp reverted curis termination date style margin margin bottom text indent font size font family time roman curis exercise right obtain font style white space nowrap exclusive font license curis hereby exercise right obtain font style white space nowrap exclusive font license forth section nbsp license agreement font style white space nowrap exclusive font license subject paragraph nbsp this transition agreement including those provision section nbsp license agreement that incorporated herein reference party agree that font style white space nowrap exclusive font license party respective right obligation under section nbsp license agreement effective termination date except that notwithstanding provision clause nbsp section nbsp license agreement curis elect have debiopharm transfer assign debio nbsp curis style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ransition small table style margin margin bottom text indent font size font family time roman current status development activity debiopharm hereby represents warrant curis that exhibit nbsp this transition agreement style margin margin bottom text indent font size font family time roman list preclinical other font style white space nowrap clinical font study clinical trial compound product conducted behalf debiopharm accurately indicate each case whether such study trial completed ongoing termination date style margin margin bottom text indent font size font family time roman describe product manufacturing process development formulation chemistry manufacturing control work conducted behalf debiopharm accurately indicate each case whether such work completed ongoing termination date style margin margin bottom text indent font size font family time roman identify each contract manufacturing organization other vendor that performed product manufacturing process development formulation work manufactured compound product behalf debiopharm style margin margin bottom text indent font size font family time roman describe each assay developed behalf debiopharm with respect compound product including without limitation diagnostic pharmacokinetic pharmacodynamics clinical sample evaluation assay style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom text indent font size font family time roman halo trial debiopharm shall cease enrollment trial including halo trial termination date subject compliance with applicable rule regulation requirement applicable regulatory authority current good clinical practice protocol halo trial consistent with good medical judgment applicable ethical standard requirement applicable ethic committee institutional review board approval halo trial debiopharm shall perform each following obligation with respect halo trial within applicable period specified below style margin margin bottom text indent font size font family time roman wind down close halo trial participating site within nbsp after termination date style margin margin bottom text indent font size font family time roman within nbsp after completion wind down close halo trial france united kingdom spain hungary complete submit declaration halo trial including information required submitted therewith each regulatory authority ethic committee france hungary spain united kingdom style margin margin bottom text indent font size font family time roman complete deliver curis final clinical study report result halo trial within nbsp month after termination date style margin margin bottom text indent font size font family time roman nbsp supply required quantity product clinical site spain patient compassionate only compassionate patient indefinite period after termination date nbsp perform necessary action pertaining this supply product such compassionate accordance with applicable regulation spain decision relevant competent authority nbsp described paragraph nbsp this transition agreement provide curis with timely reporting serious adverse event other critical reportable safety event experienced compassionate patient debiopharm expense under debiopharm sole responsibility style margin margin bottom text indent font size font family time roman transition plan party desire nbsp ensure efficient orderly transition curis ongoing product development other than halo trial manufacturing process development formulation work nbsp effect efficient expeditious transfer curis third party designee such compound product manufacturing technology analytical other assay process development know necessary enable curis such designee manufacture compound product that debiopharm shall perform curis shall cooperate with debiopharm performance activity forth transition plan attached this transition agreement exhibit nbsp transition plan debiopharm shall perform transition plan activity accordance with applicable rule regulation requirement applicable regulatory authority shall commercially reasonable effort perform each such activity within time frame forth transition plan complete such activity later than expiry transition period curis reasonable request from time time during transition period debiopharm shall make qualified debiopharm representative reasonably available curis provide necessary technical assistance respond reasonable question otherwise facilitate performance transition plan style margin margin bottom text indent font size font family time roman data transfer debiopharm shall transfer deliver curis data information relating compound product debiopharm affiliate control possession including without limitation final report clinical trial other study compound product conducted behalf debiopharm nbsp extent that such style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman data information exists termination date promptly after termination date nbsp extent that such data information collected generated after termination date wind down close halo trial other clinical trial conducted debiopharm performance transition plan activity promptly upon collection generation generated third party promptly following delivery debiopharm same debiopharm represents warrant curis that each report clinical trial other study compound product delivered debiopharm curis that identified final will final form will have received final internal sign debiopharm prior delivery curis style margin margin bottom text indent font size font family time roman data source document extent that debiopharm required applicable debiopharm shall retain cause retained data source document underlying data regulatory submission made debiopharm affiliate with respect compound product applicable retention period required retention period debiopharm shall upon reasonable advance written notice curis during regular business hour make such data source document available contractor office review copying audit curis representative after expiration applicable retention period debiopharm destroy such data source document upon nbsp notice curis unless during such notice period curis request writing that original such data source document delivered curis designee which case debiopharm shall deliver same curis designee accordance with curis written direction curis cost style margin margin bottom text indent font size font family time roman manufacturing arrangement debiopharm shall provide contact information include primary contact name email address telephone number also shall promptly provide such introduction contract manufacturing organization other vendor identified exhibit nbsp hereto curis request during transition period shall deliver each such vendor such written notice authorization necessary such vendor disclose provide curis curis access respective agreement between debiopharm such vendor data result service performed such vendor behalf debiopharm with respect compound product debio nbsp service including without limitation data documentation batch record source document report regarding debio nbsp service compound product material such vendor possession style margin margin bottom text indent font size font family time roman clinical material debiopharm represents warrant that nbsp exhibit nbsp this transition agreement forth approximate quantity location currently available clinical material possession control debiopharm termination date including starting material finished product bulk finished product clinical drug product including material collectively material except designated cgmp exhibit material were manufactured accordance with cgmp termination date curis shall owner remaining product clinical material within which comprised nbsp blister package that hold total nbsp tablet material which curis will have right clinical study within nbsp after receipt payment material accordance with paragraph nbsp this transition agreement debiopharm shall deliver material curis designee address specified curis writing during transition period debiopharm curis shall determine which material listed exhibit shall kept storage transferred curis disposed accordance with applicable regulation debiopharm will retain agreed selected material kept storage maximum period month termination date curis style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman future sake clarity debiopharm will responsible retesting such material including currently ongoing stability other testing program curis will debiopharm such material kept storage rate that equal invoiced cost converted united state dollar termination date debiopharm will provide curis with sufficient documentation substantiate invoiced cost manufacturing contract related invoice during transition period debiopharm will provide contact information including primary contact name email address telephone number vendor listed exhibit style margin margin bottom text indent font size font family time roman biological sample debiopharm represents warrant that exhibit nbsp this transition agreement forth nature location biological sample collected behalf debiopharm development compound product that possession control debiopharm termination date debiopharm will provide curis with quantity such biological sample requested curis during transition period debiopharm will provide contact information including primary contact name email address telephone number vendor listed exhibit style margin margin bottom text indent font size font family time roman change sponsorship letter within nbsp after termination date debiopharm shall submit change sponsorship letter transferring ownership nbsp curis curis shall submit acknowledgment letter confirming acceptance style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small egulatory small table style margin margin bottom text indent font size font family time roman regulatory filing debiopharm represents warrant that ctas listed paragraph this transition agreement only inds filed behalf debiopharm affiliate with respect compound product with regulatory authority ethic committee prior termination date without limiting generality paragraph nbsp this transition agreement debiopharm shall take such action make such submission regulatory authority necessary close terminate debio nbsp within nbsp after termination date notwithstanding foregoing curis acknowledges that clinical study report halo trial might available expiry transition period debiopharm commits completing within nbsp month after termination date deliver such curis soon reasonably possible upon completion such report style margin margin bottom text indent font size font family time roman safety reporting until such time debio nbsp closed debiopharm shall continue responsible regulatory authority ethic committee reporting obligation under debio nbsp subject requirement applicable action request regulatory authority ethic committee after been closed debiopharm shall have further regulatory authority ethic committee reporting obligation other pharmacovigilance obligation with respect product provided however that debiopharm shall thereafter remain obligated forward promptly event within nbsp receipt alliance manager identified safety contact curis adverse drug experience report with respect product that debiopharm affiliate receive from third party debiopharm further agrees provide curis with timely reporting serious adverse event other critical reportable safety event experienced compassionate patient debiopharm expense under debiopharm sole responsibility style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom text indent font size font family time roman right reference access debiopharm hereby grant curis affiliate third party licensee right access cross reference debio nbsp filing submission made debiopharm affiliate with regulatory authority ethic committee relating compound product debiopharm shall promptly upon request curis file with applicable regulatory authority such letter access cross reference necessary accomplish intent this paragraph nbsp style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ntellectual small small roperty small table style margin margin bottom text indent font size font family time roman intellectual property representation warranty debiopharm represents warrant covenant curis that debiopharm granted shall grant third party affiliate license right under debiopharm intellectual property right that would conflict with font style white space nowrap exclusive font license granted curis debiopharm further represents warrant curis that termination date style margin margin bottom text indent font size font family time roman debiopharm granted third party affiliate license sublicense other right regarding compound product under curis intellectual property right style margin margin bottom text indent font size font family time roman only debiopharm patent filed behalf debiopharm affiliate before termination date patent application nbsp patent application style margin margin bottom text indent font size font family time roman there joint patent style margin margin bottom text indent font size font family time roman received written notice from third party claiming that manufacture sale compound product debiopharm prior termination date infringes patent owned controlled third party style margin margin bottom text indent font size font family time roman party legal action suit proceeding relating compound product debiopharm intellectual property right curis intellectual property right received written communication from third party threatening such action suit proceeding style margin margin bottom text indent font size font family time roman prosecution maintenance curis patent except expressly forth this paragraph nbsp curis shall solely responsible prosecution maintenance curis patent from after termination date curis sole expense provided that debiopharm shall solely responsible patent cost incurred prior termination date whether invoiced debiopharm before after termination date later than nbsp after termination date debiopharm shall notify outside patent counsel writing transfer curis full responsibility control over prosecution maintenance curis patent debiopharm shall provide reasonable cooperation assistance curis necessary curis assume full responsibility control over prosecution maintenance curis patent such cooperation assistance include execution document that need submitted patent office curis prosecute maintain curis patent throughout world style margin margin bottom text indent font size font family time roman assignment curis debiopharm patent effective termination date debiopharm hereby assigns curis right title interest patent application good sufficient consideration provided this transition agreement including forth paragraph nbsp nbsp this transition agreement after style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman termination date promptly following curis request debiopharm agrees execute deliver curis patent assignment such form curis patent counsel reasonably deems appropriate filing with patent trademark office evidencing assignment curis patent application patent application shall deemed curis patent termination date paragraph nbsp this transition agreement shall apply style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small utual small small epresentations small small small small arranties small small isclaimers small table style margin margin bottom text indent font size font family time roman mutual representation warranty each party represents warrant covenant other that style margin margin bottom text indent font size font family time roman duly organized validly existing under state country incorporation full corporate power authority enter into this transition agreement carry provision hereof style margin margin bottom text indent font size font family time roman execution delivery performance this transition agreement conflict with agreement instrument oral written which party which bound style margin margin bottom text indent font size font family time roman granted shall grant right third party which would conflict with right granted other party hereunder style margin margin bottom text indent font size font family time roman disclaimer except expressly forth this transition agreement each party expressly disclaims warranty kind express implied including without limitation warranty design merchantability fitness particular purpose font style white space nowrap infringement font intellectual property right third party arising from course dealing usage trade practice style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small ndemnification small table style margin margin bottom text indent font size font family time roman debiopharm addition debiopharm indemnification obligation under section nbsp license agreement which survive termination license agreement debiopharm shall indemnify defend hold harmless curis indemnitees from against loss which curis indemnitee become subject result claim third party extent such loss arise result from breach debiopharm representation warranty covenant obligation this transition agreement except each case extent such claim caused gross negligence willful misconduct curis style margin margin bottom text indent font size font family time roman curis addition curis indemnification obligation under section nbsp license agreement which survive termination license agreement curis shall indemnify defend hold harmless debiopharm indemnitees from against loss which debiopharm indemnitee become subject result claim third party extent such loss arise result from nbsp breach curis representation warranty covenant obligation this transition agreement nbsp development importation exportation storage handling transportation manufacture other disposition compound product curis affiliate after termination date except each case extent such claim caused gross negligence willful misconduct debiopharm style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom text indent font size font family time roman indemnification procedure party respective indemnification obligation under this transition agreement shall subject section nbsp license agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small onfidentiality small table style margin margin bottom text indent font size font family time roman confidential information clarity confidential information includes information disclosed party affiliate other party affiliate after termination date pursuant this transition agreement provided however that from after termination date data information regarding compound product regardless which party first disclosed such data information other party whether such data information disclosed before after termination date shall deemed confidential information curis curis shall deemed disclosing party debiopharm receiving party with respect thereto addition party agree that term this transition agreement shall treated confidential information both party style margin margin bottom text indent font size font family time roman survival confidentiality obligation article nbsp license agreement shall survive termination license agreement provided however that notwithstanding article nbsp license agreement contrary effective termination date style margin margin bottom text indent font size font family time roman subject section nbsp license agreement paragraph nbsp this transition agreement neither party shall name other party variation adaptation thereof trademark tradename other designation owned other party affiliate name officer employee agent purpose without prior written consent other party each instance notwithstanding foregoing other party shall event entitled notified receive full copy publication disclosure using name variation adaptation thereof trademark tradename other designation that owns style margin margin bottom text indent font size font family time roman section nbsp license agreement shall terminate further force effect style margin margin bottom text indent font size font family time roman section nbsp license agreement shall survive termination license agreement solely with respect data from halo trial except foregoing neither debiopharm contractor shall have right publish data other information regarding compound product from after termination date style margin margin bottom text indent font size font family time roman result clinical study performed debiopharm compound shall published eudract database style margin margin bottom text indent font size font family time roman addition publication forth paragraph this transition agreement curis recognizes that subcontractor debiopharm including without limitation academic institution provider service debiopharm provide consent public oral presentation article information pertaining their activity related compound product from time time after termination date curis shall have right review comment material proposed public oral presentation publication debiopharm that includes data other result preclinical clinical development compound product includes confidential information curis before such material submitted publication debiopharm shall deliver complete copy curis least nbsp prior submitting material publisher initiating other disclosure curis shall review such material give comment debiopharm within style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman nbsp delivery such material curis with respect public oral presentation material abstract curis shall make reasonable effort expedite review such material abstract shall return such item soon practicable debiopharm with appropriate comment event later than nbsp from date delivery curis debiopharm shall comply with curis request delete reference curis confidential information such material addition such publication contains patentable subject matter then curis request debiopharm shall ensure that subcontractor either delete patentable subject matter from such publication delay submission publication other public disclosure period additional nbsp that appropriate patent application prepared filed sake clarity this clause shall also apply public presentation publication debiopharm after termination date style margin margin bottom text indent font size font family time roman press release debiopharm agrees that curis issue press release upon execution this transition agreement form reasonably agreed party party further acknowledge that each party desire required issue subsequent press release make other public disclosure relating this transition agreement term party agree consult with each other reasonably good faith with respect text timing such press release other public disclosure prior issuance thereof provided that party unreasonably withhold consent such release that either party issue such press release determines reasonably necessary comply with regulation addition following initial press release announcing this transition agreement each party shall free disclose without other party prior written consent existence this transition agreement identity other party those term this transition agreement which have already been publicly disclosed accordance herewith style margin margin bottom text indent font size font family time roman curis right publish from after termination date curis shall free publish such public oral presentation manuscript abstract data other information regarding compound product without restriction subject paragraph nbsp this transition agreement style font size margin margin bottom nbsp table style border collapse collapse font family time roman font size border cellpadding cellspacing width width valign align left align left valign small iscellaneous small table style margin margin bottom text indent font size font family time roman surviving provision license agreement notwithstanding article nbsp license agreement contrary only section nbsp amended subject paragraph nbsp this transition agreement article nbsp amended except forth paragraph nbsp this transition agreement license agreement shall survive termination license agreement pursuant this transition agreement style margin margin bottom text indent font size font family time roman incorporation reference article nbsp license agreement hereby incorporated reference this transition agreement mutatis mutandis such that reference this agreement such article license agreement shall interpreted refer this transition agreement style margin margin bottom text indent font size font family time roman notice notice required permitted made given either party hereto pursuant this transition agreement license agreement shall sufficiently made given date mailing sent such party certified registered mail postage prepaid addressed address forth below such other address shall designate written notice other party follows style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom margin left font size font family time roman debiopharm style margin margin bottom margin left font size font family time roman debiopharm international style margin margin bottom margin left font size font family time roman forum laquo egrave demain raquo style margin margin bottom margin left font size font family time roman chemin messidor style margin margin bottom margin left font size font family time roman lausanne style margin margin bottom margin left font size font family time roman switzerland style margin margin bottom margin left font size font family time roman attention director legal affair style margin margin bottom margin left font size font family time roman curis style margin margin bottom margin left font size font family time roman curis style margin margin bottom margin left font size font family time roman nbsp maguire road style margin margin bottom margin left font size font family time roman lexington style margin margin bottom margin left font size font family time roman style margin margin bottom margin left font size font family time roman attention chief executive officer style margin margin bottom text indent font size font family time roman complete agreement party hereto acknowledge that this transition agreement surviving provision license agreement forth paragraph nbsp this transition agreement expressly amended this transition agreement collectively forth entire agreement understanding party supersede prior written oral agreement understanding with respect subject matter hereof thereof except expressly forth section nbsp license agreement style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom text indent font size font family time roman small small small itness small small hereof small party have caused this transition agreement executed their duly authorized representative termination date style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign colspan small ebiopharm small small nternational small valign bottom valign bottom colspan small uris small small small style font size height height colspan height colspan height colspan style font family time roman font size valign valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman thierry mauvernay valign bottom valign bottom valign bottom valign bottom style margin margin bottom border bottom solid font size font family time roman michael gray style font family time roman font size valign name valign bottom valign bottom thierry mauvernay valign bottom valign bottom name valign bottom valign bottom michael gray style font family time roman font size valign title valign bottom valign bottom delegate board valign bottom valign bottom title valign bottom valign bottom chief financial chief business officer style font family time roman font size valign date valign bottom valign bottom nbsp february valign bottom valign bottom date valign bottom valign bottom table style margin margin bottom font size font family time roman exhibit index style margin margin bottom font size font family time roman exhibit debiopharm development activity style margin margin bottom font size font family time roman exhibit transition plan style margin margin bottom font size font family time roman exhibit debiopharm vendor material style margin margin bottom font size font family time roman exhibit material style margin margin bottom font size font family time roman exhibit available biological sample style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center debiopharm development activity style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap align center style border bottom solid width font size font family time roman align center debiopharm study number valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center study title valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center status valign bottom nbsp valign bottom nowrap align center style margin margin bottom font size font family time roman align center report nbsp available style margin margin bottom border bottom solid width font size font family time roman align center nbsp transfer nbsp within bgcolor cceeff style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp valign bottom align center table style margin margin bottom font size font family time roman confidential material omitted filed separately with security exchange commission total page were omitted style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom nbsp nbsp valign align center debiopharm curis valign bottom nbsp nbsp valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center transition plan style margin margin bottom font size font family time roman debiopharm responsibility under technology transfer plan follows style margin margin bottom font size font family time roman within nbsp effective date debiopharm will provide curis with following documentation information either electronic hard copy format style margin margin bottom text indent font size font family time roman general document style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman other document style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman study related document style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman transfer control responsibility from debiopharm curis style margin margin bottom text indent font size font family time roman style margin margin bottom text indent font size font family time roman technology transfer plan management style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom valign align center debiopharm curis valign bottom valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center debiopharm vendor material style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width style font family time roman font size valign bottom nowrap align center style border bottom solid width font size font family time roman align center manufacturer valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center responsibility style font family time roman font size valign align center valign bottom nbsp nbsp valign align center table style margin margin bottom font size font family time roman confidential material omitted filed separately with security exchange commission total page omitted style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom nbsp nbsp valign align center debiopharm curis valign bottom nbsp nbsp valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center material style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap align center style border bottom solid width font size font family time roman align center product valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center storage location valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center batch number valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center description valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center approximate quantity style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom nbsp nbsp valign align center debiopharm curis valign bottom nbsp nbsp valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center deuterated compound style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap align center style border bottom solid width font size font family time roman align center product valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center storage location valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center batch number valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center approximate quantity style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp nbsp manufacturer valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom table style margin margin bottom font size font family time roman align center debio metabolite style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap align center style border bottom solid width font size font family time roman align center product valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center storage location valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center batch number valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center approximate quantity style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom table style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom nbsp nbsp valign align center debiopharm curis valign bottom nbsp nbsp valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center debio reference standard style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap align center style border bottom solid width font size font family time roman align center product valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center storage location valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center batch number valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center approximate quantity style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size font family time roman align center others compound style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width valign bottom width style font family time roman font size valign bottom nowrap align center style border bottom solid width font size font family time roman align center product valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center storage location valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center batch number valign bottom nbsp nbsp valign bottom nowrap align center style border bottom solid width font size font family time roman align center approximate quantity style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom nbsp nbsp valign align center debiopharm curis valign bottom nbsp nbsp valign align right page table style page break before always size style color width align center style margin margin bottom font size font family time roman execution copy style font size margin margin bottom nbsp style margin margin bottom font size font family time roman align center exhibit style margin margin bottom font size font family time roman align center available biological sample style font size margin margin bottom nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width valign bottom width width valign bottom width width style font family time roman font size valign bottom nowrap align center style margin margin bottom font size font family time roman align center debiopharm style margin margin bottom border bottom solid width font size font family time roman align center study nbsp number valign bottom nbsp nbsp valign bottom align center style margin margin bottom font size font family time roman align center study nbsp nbsp style margin margin bottom font size font family time roman align center central style margin margin bottom font size font family time roman align center style margin margin bottom font size font family time roman align center secondary style margin margin bottom border bottom solid width font size font family time roman align center valign bottom nbsp nbsp valign bottom align center style margin margin bottom font size font family time roman align center study style margin margin bottom border bottom solid width font size font family time roman align center title valign bottom nbsp nbsp valign bottom align center style border bottom solid width font size font family time roman align center status valign bottom nbsp nbsp valign bottom align center style border bottom solid width font size font family time roman align center type nbsp nbsp sample style font family time roman font size valign align center style margin left text indent font size font family time roman align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center valign bottom nbsp nbsp valign bottom align center table style margin margin bottom font size font family time roman confidential material omitted filed separately with security exchange commission total page omitted style margin margin bottom font size nbsp table cellspacing cellpadding width border style border collapse collapse font family time roman font size align center width valign bottom width width valign bottom width width style font family time roman font size valign termination transition agreement valign bottom nbsp nbsp valign align center debiopharm curis valign bottom nbsp nbsp valign align right page table body html text document